Turn Therapeutics (TTRX) Gains from Investment Securities (2024 - 2026)

Turn Therapeutics' Gains from Investment Securities history runs 3 years deep, the most recent figure standing at $1.9 million for Q1 2026.

• In Q1 2026, Gains from Investment Securities changed N/A year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $1.9 million (changed N/A YoY), while the FY2025 annual figure was $40030.0, down 97.62% from the prior year.
• Gains from Investment Securities was $1.9 million for Q1 2026 at Turn Therapeutics, up from $40030.0 in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $1.9 million in Q1 2026 to a low of $40030.0 in Q4 2025.
• Historically, Gains from Investment Securities has averaged $1.3 million across 3 years, with a median of $1.7 million in 2024.
• Biggest YoY gain for Gains from Investment Securities was 97.62% in 2025; the steepest drop was 97.62% in 2025.
• A 3-year view of Gains from Investment Securities shows it stood at $1.7 million in 2024, then plunged by 97.62% to $40030.0 in 2025, then jumped by 4751.82% to $1.9 million in 2026.
• The last three Gains from Investment Securities figures came in at $1.9 million (Q1 2026), $40030.0 (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.